The group has provided an update for trading in the six months to March, with the recent COVID-19 issues expected to have a material impact on short-term trading. Trading for FY 2020 is expected to be H2 weighted with more resilient performances in A&D and lifesciences. The group has a strong order book, with some orders in EU and US being pushed back in the near term. We reduce revenues by 10%, which has a drop through impact of 42% on profits and EPS. We also place our FY 2021 forecasts
07 Apr 2020
Gooch & Housego - COVID-19 trading update
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Gooch & Housego - COVID-19 trading update
Gooch & Housego PLC (GHH:LON) | 523 0 0.0% | Mkt Cap: 134.9m
- Published:
07 Apr 2020 -
Author:
David Buxton -
Pages:
4
The group has provided an update for trading in the six months to March, with the recent COVID-19 issues expected to have a material impact on short-term trading. Trading for FY 2020 is expected to be H2 weighted with more resilient performances in A&D and lifesciences. The group has a strong order book, with some orders in EU and US being pushed back in the near term. We reduce revenues by 10%, which has a drop through impact of 42% on profits and EPS. We also place our FY 2021 forecasts